MENU
+Compare
BPTSY
Stock ticker: OTC
AS OF
Jul 16 closing price
Price
$1.80
Change
+$0.47 (+35.34%)
Capitalization
5.26M

BPTSY Biophytis SA Forecast, Technical & Fundamental Analysis

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases... Show more

BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BPTSY with price predictions
Aug 06, 2025

Momentum Indicator for BPTSY turns positive, indicating new upward trend

BPTSY saw its Momentum Indicator move above the 0 level on July 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

BPTSY moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BPTSY crossed bullishly above the 50-day moving average on July 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

BPTSY broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BPTSY entered a downward trend on July 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.047). P/E Ratio (0.000) is within average values for comparable stocks, (58.309). BPTSY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.504). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (276.800).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BPTSY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BPTSY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCM5.270.22
+4.36%
Concord Medical Services Holding Limited
KHC27.260.22
+0.81%
Kraft Heinz Company (The)
SLNO81.19-0.44
-0.54%
Soleno Therapeutics
SLI2.51-0.04
-1.57%
Standard Lithium Ltd
BLDP1.83-0.03
-1.61%
Ballard Power Systems

BPTSY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BPTSY has been closely correlated with CDTX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if BPTSY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTSY
1D Price
Change %
BPTSY100%
N/A
CDTX - BPTSY
92%
Closely correlated
+0.36%
NGNE - BPTSY
38%
Loosely correlated
-0.75%
RNAZ - BPTSY
36%
Loosely correlated
-3.39%
VRCA - BPTSY
27%
Poorly correlated
+9.20%
BRNS - BPTSY
26%
Poorly correlated
-5.07%
More